Central America vs Luxembourg: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Luxembourg
97.0%
in 2024
Central America rank
13th
Luxembourg rank
11th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Luxembourg
How they compare
Luxembourg currently reports 97.0% against 80.0% in Central America, a difference of 17.0%.
That makes Luxembourg's figure about 1.2 times Central America's.
Across all 17 years both countries report, Luxembourg has been ahead every year.
Central America ranks 13th and Luxembourg ranks 11th of 37 groups.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central America | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.5% | 86.0% | 64.5% | Luxembourg |
| 2010s | 86.5% | 93.4% | 6.9% | Luxembourg |
| 2020s | 81.4% | 96.6% | 15.2% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Luxembourg?
- Luxembourg, at 97.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Luxembourg?
- 17.0%, with Luxembourg ahead.
- How many years of comparable data are there for Central America and Luxembourg?
- 17 years are reported by both, from 2008 to 2024.
- How do Central America and Luxembourg rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Luxembourg ranks 11th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.